Pfizer commits to stem cell therapeutics
Interviewee/Contributor
Ruth McKernan
Organisation
Pfizer Regenerative Medicine
Research Directory
How consolidation may affect biotech innovation
Interviewee/ContributorGareth WilliamsOrganisationMarks & Clerk LLPMerck Serono Ventures invests in early technology
Interviewee/ContributorRoel BulthuisOrganisationMerck Serono VenturesBIO: Industry finds ways to weather the storm
Pfizer commits to stem-cell therapeutics
Interviewee/ContributorRuth McKernanOrganisationPfizer Regenerative MedicineNovimmune's antibody strategy attracks investors
Interviewee/ContributorJack BarbutOrganisationNovimmune SANovimmune's antibody strategy attracks investors
Interviewee/ContributorLuca BolligerOrganisationNovimmune SAAn interview with Seventure Partners: Is grass greener on the other side of the Manche?
Interviewee/ContributorIain WilcockOrganisationSeventure PartnersEMEA explains new certification scheme
Novacta targets C. difficile the natural way
Interviewee/ContributorMichael DawsonOrganisationNovacta Biosystems Ltd